Skip to content

A Randomized Trial Regarding Outcomes of Micro-Needling and Autologous Platelet-Rich Plasma in the Management of Atrophic Acne Scars

A Randomized Trial Regarding Outcomes of Micro-Needling and Autologous Platelet-Rich Plasma in the Management of Atrophic Acne Scars

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056703
Enrollment
35
Registered
2023-08-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

Intervention1: Microneedling: eliminate all oils from the skin, the patients cutaneous surface will first be washed with ethyl alcohol and then with ether. Then, after being covered for 30 minutes, a

Sponsors

Jawaharlal Nehru Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects aged from 18 years and above who have not received previous treatment for acne scars

Exclusion criteria

Exclusion criteria: Subjects with platelet or blood coagulation abnormalities, chronic liver illness, or auto-immune diseases will be excluded. Subjects who have used systemic or topical retinoids in the previous 6 months or two weeks, Subjects with chronic debilitating conditions, uncontrolled systemic infection, malignancy history, or keloid inclination, as well as subjects with unreasonable expectations. Females who will be pregnant or nursing, or who will be undergoing hormone management all these cases were excluded from our research. Subjects who did not finish their management sessions or follow-up duration will also be excluded.

Design outcomes

Primary

MeasureTime frame
The goal of this research is to assess the therapeutic effectiveness and safety of micro-needling with autologous platelet-rich plasma in the management of atrophic acne scars.Timepoint: The goal of this research is to assess the therapeutic effectiveness and safety of micro-needling with autologous platelet-rich plasma in the management of atrophic acne scars after 6-8 weeks post therapy

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Bhushan Madke

Datta Meghe Institute of Higher Education and Research

drbhushan81@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026